Previous 10 |
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away ™ through their direct response partner, DEG Productions. CORAL SPRINGS, Fla., June 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pha...
CORAL SPRINGS, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that they have partnered...
CORAL SPRINGS, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin ® and Pet Pain-Away ™ in the over-the-counter (OTC) pain management market, and which is also developing treatments fo...
CORAL SPRINGS, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin® and ...
CORAL SPRINGS, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin ® and Pet Pain-Away ™ in the over-the-counter (OTC) pain management market, and which is also developing treatments fo...
CORAL SPRINGS, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin® and Pet Pain-Away™...
CORAL SPRINGS, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- —via OTC PR WIRE-- -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin®...
CORAL SPRINGS, Fla., Jan. 18, 2018 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that they have partnered wi...
News, Short Squeeze, Breakout and More Instantly...
CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, t...
Odyssey Marine Exploration Inc. (OMEX) is expected to report for quarter end 2023-06-30 The Very Good Food Company Inc. (VGFCQ) is expected to report for quarter end 2023-06-30 SeaChange International Inc. (SEAC) is expected to report for Q1 2024 Allena Pharmaceuticals Inc. (ALNAQ) is...
QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...